Literature DB >> 12545558

Optimized production of high-titer recombinant adeno-associated virus in roller bottles.

Y L Liu1, K Wagner, N Robinson, D Sabatino, P Margaritis, W Xiao, R W Herzog.   

Abstract

Adeno-associated viral (AAV) vectors are used for in vivo gene transfer in a number of preclinical models of genetic diseases (including large-animal models) and are currently being tested in clinical trials for treatment of hemophilia B and cystic fibrosis. Protocols for production of AAV vectors in a helper virus-free system are available and are based on transient transfection of HEK-293 cells with multiple plasmids. Scale-up of vector production has been labor intensive and inefficient because of a lack of larger culture vessels suitable for growth of adherent cells, large-scale transfection, and vector production. Here we report efficient production of AAV vector in roller bottles, which represents a 10-fold scale-up from the conventional flask or plate method. Optimized production yielded greater than 10(13) vector genomes per bottle and was as cost effective as published protocols using plates. Successful vector production by this method was dependent on optimization of transfection by calcium phosphate precipitation, of monitoring of cell growth (by measurement of glucose consumption), of cell culture conditions, and CO2/air exchange with the culture vessel.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12545558     DOI: 10.2144/03341dd07

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  29 in total

1.  High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy.

Authors:  Mengxin Li; Giridhara R Jayandharan; Baozheng Li; Chen Ling; Wenqin Ma; Arun Srivastava; Li Zhong
Journal:  Hum Gene Ther       Date:  2010-10-06       Impact factor: 5.695

Review 2.  Progress and challenges in viral vector manufacturing.

Authors:  Johannes C M van der Loo; J Fraser Wright
Journal:  Hum Mol Genet       Date:  2015-10-30       Impact factor: 6.150

3.  Molecular cloning, overexpression, and an efficient one-step purification of α5β1 integrin.

Authors:  Lawrence J Tartaglia; Antonette Bennett; Alexander S Plattner; Nicholas Muzyczka; Chen Ling; Arun Srivastava; Mavis Agbandje-McKenna
Journal:  Protein Expr Purif       Date:  2013-08-29       Impact factor: 1.650

4.  Systemic protein delivery by muscle-gene transfer is limited by a local immune response.

Authors:  Lixin Wang; Eric Dobrzynski; Alexander Schlachterman; Ou Cao; Roland W Herzog
Journal:  Blood       Date:  2005-02-15       Impact factor: 22.113

5.  Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer.

Authors:  Mario Cooper; Sushrusha Nayak; Brad E Hoffman; Cox Terhorst; Ou Cao; Roland W Herzog
Journal:  Hum Gene Ther       Date:  2009-07       Impact factor: 5.695

6.  Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells.

Authors:  C Jenny; E Toublanc; O Danos; O-W Merten
Journal:  Cytotechnology       Date:  2005-09       Impact factor: 2.058

7.  Impact of the underlying mutation and the route of vector administration on immune responses to factor IX in gene therapy for hemophilia B.

Authors:  Ou Cao; Brad E Hoffman; Babak Moghimi; Sushrusha Nayak; Mario Cooper; Shangzhen Zhou; Hildegund C J Ertl; Katherine A High; Roland W Herzog
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

8.  The Balance between CD8+ T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector Dose.

Authors:  Sandeep R P Kumar; Brad E Hoffman; Cox Terhorst; Ype P de Jong; Roland W Herzog
Journal:  Mol Ther       Date:  2017-03-09       Impact factor: 11.454

9.  Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells.

Authors:  Eric Dobrzynski; Julie C Fitzgerald; Ou Cao; Federico Mingozzi; Lixin Wang; Roland W Herzog
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-10       Impact factor: 11.205

10.  Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicity.

Authors:  Ashley T Martino; Sushrusha Nayak; Brad E Hoffman; Mario Cooper; Gongxian Liao; David M Markusic; Barry J Byrne; Cox Terhorst; Roland W Herzog
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.